The latest price target for Zura Bio (NASDAQ:ZURA) was reported by Chardan Capital on March 23, 2026. The analyst firm set a price target for $11.00 expecting ZURA to rise to within 12 months (a possible 94.69% upside). 10 analyst firms have reported ratings in the last year.

The latest analyst rating for Zura Bio (NASDAQ:ZURA) was provided by Chardan Capital, and Zura Bio maintained their buy rating.

There is no last upgrade for Zura Bio

There is no last downgrade for Zura Bio.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zura Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zura Bio was filed on March 23, 2026 so you should expect the next rating to be made available sometime around March 23, 2027.

While ratings are subjective and will change, the latest Zura Bio (ZURA) rating was a maintained with a price target of $10.00 to $11.00. The current price Zura Bio (ZURA) is trading at is $5.65, which is out of the analyst’s predicted range.